Dyadic International Inc DYAI

Healthcare Biotechnology

Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

NDAQ:DYAI - Post by User

Dyadic International Inc

<< Previous

Bullboard Posts

Next >>

Post by schoolofrockon Oct 08, 2020 12:56pm

90 Views

Post# 31689315

Oct 14th Virtual Roadshow with President & CEO Mark Emalfarb

Join Dyadic International President & CEO, Mark Emalfarb for this exclusive corporate presentation, followed by a Q & A session moderated by Ahu Demir, Ph. D., Noble's Biotechnology Analyst, featuring questions taken from the audience. Registration is free, but attendance is limited to 100.

https://attendee.gotowebinar.com/register/3580219176031606541

User image